article thumbnail

Epilepsy and MMJ: Exploring the Promising Treatment Benefits

MMJ Recs

Epilepsy is a complex neurological disorder that affects millions of people worldwide, causing recurrent seizures that can significantly impact the quality of life. Medical Marijuana for Epilepsy Treatment Medical marijuana, often referred to as MMJ, is a term used to describe the use of cannabis and its derivatives for therapeutic purposes.

Epilepsy 105
article thumbnail

NYU’s Groundbreaking CBD/Epilepsy Study, WA’s Mushroom Legalization in Peril, & MD Pushes for Social Equity

Veriheal

An NYU study found that CBD could help those with epilepsy, Washington’s mushroom legalization bill hit a major roadblock, and Maryland is looking to include social equity in its forthcoming recreational market. This new CBD-epilepsy study comes from NYU’s Grossman School of Medicine. So where does CBD fit into all this?

Epilepsy 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Marijuana as a treatment for epilepsy

Cannabis Info

Marijuana as a treatment for epilepsy. Medical cannabis is showing great potential in the treatment of epilepsy. Cannabis is issued medicinally for a plethora or disorders, and one that it seems to affect very positively is epilepsy. WHAT EXACTLY IS EPILEPSY? CONVENTIONAL TREATMENT. CANNABIS AS A POTENTIAL TREATMENT.

article thumbnail

CBD, Autism and Epilepsy – What you Need to Know

Otherside Farms

ASD and Epilepsy. There is a strong link between ASD and epilepsy. In fact, research shows that about 32% of people who suffer from epilepsy are also on the autistic spectrum, and likewise, 20-30% of children on the autistic spectrum develop epilepsy. Help for people with ASD and Epilepsy. CBD and Epilepsy.

article thumbnail

GW suffers major blow as US sinks bid to patent cannabinoids for epilepsy

Cannabis Law Report

British firm GW Pharmaceuticals is licking its wounds after US judges tossed out its attempt to patent multiple cannabinoids for epilepsy treatment following an eight-year battle. The patent, which has been embroiled in dispute since 2010, is for “the use of one or more cannabinoids in the treatment of epilepsy”.

article thumbnail

UK Children Who Suffer With Epilepsy May Soon See Relief

Veriheal

We merely report on the facts as they are presented and their implications in regards to cannabis. Unfortunately, this had a powerful impact on a small subset of residents—UK children suffering from epilepsy who had been dependent on imported medications to help control their illness. Some Kids Legitmately Need Cannabis.

article thumbnail

MyMD Pharmaceuticals to Present its Novel Therapeutic Platforms for Extending Healthy Lifespan at the H.C. Wainwright 23rd Annual Global Investment Conference September 13-15

Cannabis Law Report

(Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, will present at the H.C. During this presentation, Chris Chapman, M.D., The Company’s second drug platform, Supera-CBD, is being developed to treat chronic pain, addiction and epilepsy.